Kun Chen

2.3k total citations · 2 hit papers
31 papers, 1.6k citations indexed

About

Kun Chen is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Kun Chen has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Kun Chen's work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Kun Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Kun Chen collaborates with scholars based in China, United States and Belgium. Kun Chen's co-authors include Xuetao Cao, Juan Liu, L. Thomas, Jose Lutzky, Michael Smylie, Dirk Schadendorf, Troy H. Guthrie, Bart Neyns, William Waterfield and Steven O’Day and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Kun Chen

28 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

2009 934 citations Jedd D. Wolchok, Bart Neyns et al. The Lancet Oncology profile →
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

2022 160 citations Ruonan Zhang, Yajing Yang et al. Proceedings of the National Academy of Sciences profile →

Peers

Kun Chen

ONCOL

IMMUN

PRM

EPIDE

Sarah R. Klein United States

Wei Sheng China

Xiaomei Zhang China

Markus Hansson Sweden

Arezoo Gowhari Shabgah Iran

Rajeev Shrimali United States

Seok-Chul Yang South Korea

Terry R. Medler United States

James D. Levine United States

Tatyana Vlaykova Bulgaria

Sarah R. Klein United States

Kun Chen

674 ×0.6

ONCOL

506 ×0.7

IMMUN

406 ×0.9

157 ×0.9

PRM

164 ×1.3

EPIDE

Citations per year, relative to Kun Chen Kun Chen (= 1×) peers Sarah R. Klein

Countries citing papers authored by Kun Chen

Since Specialization

Citations

This map shows the geographic impact of Kun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Chen more than expected).

Fields of papers citing papers by Kun Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Chen. The network helps show where Kun Chen may publish in the future.

Co-authorship network of co-authors of Kun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Chen. A scholar is included among the top collaborators of Kun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Chen. Kun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Qing, Yue Peng, Zhenlin Yang, et al.. (2025). Pulmonary macrophage-targeted RNAi and mRNA co-delivery via SORT lipid nanoparticles enhances immunotherapy in lung cancer. Journal of Controlled Release. 390. 114519–114519.

Yin, Xiaomin, Zhilong He, Kun Chen, et al.. (2024). Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies. Frontiers in Pharmacology. 15. 1386929–1386929. 4 indexed citations

Chen, Kun, Yida Li, Jianjiao Ni, et al.. (2024). Identification of a novel subtype of SPP1 + macrophages expressing SIRPα: implications for tumor immune evasion and treatment response prediction. Experimental Hematology and Oncology. 13(1). 119–119. 4 indexed citations

Chen, Kun, Zhiyuan Wu, Fei Zhao, et al.. (2023). Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunity. BMC Medicine. 21(1). 315–315. 6 indexed citations

Zhang, Ruonan, Yajing Yang, Wenjing Dong, et al.. (2022). D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. Proceedings of the National Academy of Sciences. 119(8). 160 indexed citations breakdown →

Zhang, Shuguang, Kun Chen, Zhenguo Zhao, et al.. (2022). Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM). Journal of Immunotherapy. 45(6). 274–283. 12 indexed citations

Sheng, Yuling, Kun Chen, Wei Jiang, et al.. (2021). PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury. Translational Lung Cancer Research. 10(2). 685–698. 17 indexed citations

Qian, Ling, Yalei Zhang, Kun Chen, et al.. (2021). Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(2). 188632–188632. 17 indexed citations

Zhang, Mengli, et al.. (2021). Development of an Immune-Related Gene Signature for Prognosis in Melanoma. Frontiers in Oncology. 10. 602555–602555. 21 indexed citations

10.

Huang, Dandan, et al.. (2020). Induction of Autophagy by Baicalin Through the AMPK-mTOR Pathway Protects Human Skin Fibroblasts from Ultraviolet B Radiation-Induced Apoptosis. SHILAP Revista de lepidopterología. 2 indexed citations

11.

Li, Li, et al.. (2019). Downregulation of CD166 inhibits invasion, migration, and EMT in the radio-resistant human nasopharyngeal carcinoma cell line CNE-2R. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Meng, Ling‐bing, et al.. (2018). Common Injuries and Repair Mechanisms in the Endothelial Lining. Chinese Medical Journal. 131(19). 2338–2345. 16 indexed citations

13.

Wang, Mengru, Yanqiu Zhang, Meng Dang, et al.. (2018). Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer. Journal of Colloid and Interface Science. 538. 630–637. 31 indexed citations

14.

Zhang, Ming, Kun Chen, Beidong Chen, et al.. (2018). Suppression of TLR4 activation by resveratrol is associated with STAT3 and Akt inhibition in oxidized low-density lipoprotein-activated platelets. European Journal of Pharmacology. 836. 1–10. 30 indexed citations

15.

Chen, Kun, Yun Jiang, Beidong Chen, et al.. (2017). Ginkgolide B Suppresses TLR4‐Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose‐Treated HUVECs. Oxidative Medicine and Cellular Longevity. 2017(1). 9371602–9371602. 31 indexed citations

16.

Chen, Kun, Juan Liu, & Xuetao Cao. (2017). Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review. Journal of Autoimmunity. 83. 1–11. 223 indexed citations

17.

Wolchok, Jedd D., Bart Neyns, Gerald P. Linette, et al.. (2009). Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. The Lancet Oncology. 11(2). 155–164. 934 indexed citations breakdown →

18.

Fleming, Steven T., et al.. (2002). Geographic variation in breast-conserving surgery in Kentucky's Medicare population.. PubMed. 100(3). 99–103. 6 indexed citations

19.

Chen, Kun, Shu Zheng, Lun Zhou, et al.. (1997). Diagnostic value of occult fecal blood testing for colorectal cancer screening. World Journal of Gastroenterology. 3(3). 166–168. 3 indexed citations

20.

Chen, Kun, et al.. (1993). Longitudinal gompertzian analysis of non-hodgkin's lymphoma mortality in the US, 1979–1988: Demonstration of the environmental basis for rising overall mortality. Mechanisms of Ageing and Development. 67(1-2). 65–78. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact